Literature DB >> 29023917

Protein arginine methyl transferase 1- and Jumonji C domain-containing protein 6-dependent arginine methylation regulate hepatocyte nuclear factor 4 alpha expression and hepatocyte proliferation in mice.

Jie Zhao1, Abby Adams1,2, Ben Roberts2, Maura O'Neil3, Anusha Vittal1, Timothy Schmitt4, Sean Kumer4, Josiah Cox1, Zhuan Li1, Steven A Weinman1,2, Irina Tikhanovich1.   

Abstract

Alcohol is a well-established risk factor for hepatocellular carcinoma (HCC), but the mechanisms by which it promotes liver cancer are not well understood. Several studies have shown that cellular protein arginine methylation is inhibited by alcohol. Arginine methylation is controlled by the reciprocal activity of protein arginine methyltransferases, primarily protein arginine methyl transferase 1 (PRMT1), and a demethylase Jumonji C domain-containing protein 6 (JMJD6). The aim of this study was to explore the role of arginine methylation changes in alcohol pathogenesis. We found that PRMT1 activity is inhibited in livers of mice fed with alcohol compared to pair-fed mice. Using hepatocyte-specific PRMT1 knockout mice, we identified that loss of PRMT1 results in enhanced hepatocyte proliferation and a 33% increase in liver size. This increased hepatocyte proliferation was associated with reduced expression of hepatocyte nuclear factor 4 alpha (Hnf4α), an important regulator of liver tumorigenesis. We found that PRMT1 regulates Hnf4α expression directly through arginine methylation at the (Hnf4α) promoter. In the absence of PRMT1, JMJD6 can demethylate the Hnf4α promoter and suppress its expression. We were able to restore Hnf4α expression and abolish the increase in hepatocyte proliferation by knockdown of JMJD6 in PRMT1 knockout mice. Knockdown of JMJD6 in alcohol-fed mice similarly increased Hnf4α expression. We then examined whether loss of arginine methylation might play a role in alcohol-associated liver cancers. We examined 25 human HCC specimens and found a strong correlation (R = 0.8; P < 0.01) between arginine methylation levels and Hnf4α expression in these specimens, suggesting that the above mechanism is relevant in patients.
CONCLUSION: Taken together, these data suggest that PRMT1 inhibition, such as induced by alcohol, may result in epigenetic changes leading to loss of Hnf4α. This effect may contribute to alcohol's ability to promote liver tumors. (Hepatology 2018;67:1109-1126).
© 2017 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29023917      PMCID: PMC5826837          DOI: 10.1002/hep.29587

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  41 in total

Review 1.  Immunity, inflammation, and cancer.

Authors:  Sergei I Grivennikov; Florian R Greten; Michael Karin
Journal:  Cell       Date:  2010-03-19       Impact factor: 41.582

2.  Protein arginine methyltransferase 1 regulates hepatic glucose production in a FoxO1-dependent manner.

Authors:  Dahee Choi; Kyoung-Jin Oh; Hye-Sook Han; Young-Sil Yoon; Chang-Yun Jung; Seong-Tae Kim; Seung-Hoi Koo
Journal:  Hepatology       Date:  2012-10       Impact factor: 17.425

3.  Regulation of FOXO3 by phosphorylation and methylation in hepatitis C virus infection and alcohol exposure.

Authors:  Irina Tikhanovich; Sudhakiranmayi Kuravi; Roosevelt V Campbell; Kusum K Kharbanda; Antonio Artigues; Maria T Villar; Steven A Weinman
Journal:  Hepatology       Date:  2013-11-20       Impact factor: 17.425

4.  PRMT1-mediated methylation of the EGF receptor regulates signaling and cetuximab response.

Authors:  Hsin-Wei Liao; Jung-Mao Hsu; Weiya Xia; Hung-Ling Wang; Ying-Nai Wang; Wei-Chao Chang; Stefan T Arold; Chao-Kai Chou; Pei-Hsiang Tsou; Hirohito Yamaguchi; Yueh-Fu Fang; Hong-Jen Lee; Heng-Huan Lee; Shyh-Kuan Tai; Mhu-Hwa Yang; Maria P Morelli; Malabika Sen; John E Ladbury; Chung-Hsuan Chen; Jennifer R Grandis; Scott Kopetz; Mien-Chie Hung
Journal:  J Clin Invest       Date:  2015-11-16       Impact factor: 14.808

5.  Protein arginine methyltransferase 1 coactivates NF-kappaB-dependent gene expression synergistically with CARM1 and PARP1.

Authors:  Paul O Hassa; Marcela Covic; Mark T Bedford; Michael O Hottiger
Journal:  J Mol Biol       Date:  2008-01-26       Impact factor: 5.469

6.  Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.

Authors:  Sean F Altekruse; S Jane Henley; James E Cucinelli; Katherine A McGlynn
Journal:  Am J Gastroenterol       Date:  2014-02-11       Impact factor: 10.864

Review 7.  Protein arginine methylation in mammals: who, what, and why.

Authors:  Mark T Bedford; Steven G Clarke
Journal:  Mol Cell       Date:  2009-01-16       Impact factor: 17.970

Review 8.  Role of hepatocyte nuclear factor 4α (HNF4α) in cell proliferation and cancer.

Authors:  Chad Walesky; Udayan Apte
Journal:  Gene Expr       Date:  2015

9.  Dynamic distribution of histone H4 arginine 3 methylation marks in the developing murine cortex.

Authors:  Alexandra Chittka
Journal:  PLoS One       Date:  2010-11-03       Impact factor: 3.240

10.  Protein arginine methyltransferase 1 is a novel regulator of MYCN in neuroblastoma.

Authors:  Allison Eberhardt; Jeanne N Hansen; Jan Koster; Louis T Lotta; Simeng Wang; Emmett Livingstone; Kun Qian; Linda J Valentijn; Yujun George Zheng; Nina F Schor; Xingguo Li
Journal:  Oncotarget       Date:  2016-09-27
View more
  15 in total

1.  Deficiency of Mitochondrial Glycerol 3-Phosphate Dehydrogenase Contributes to Hepatic Steatosis.

Authors:  Yi Zheng; Hua Qu; Xin Xiong; Yuren Wang; Xiufei Liu; Linlin Zhang; Xiaoyu Liao; Qian Liao; Zheng Sun; Qin Ouyang; Gangyi Yang; Zhiming Zhu; Jing Xu; Hongting Zheng
Journal:  Hepatology       Date:  2019-03-15       Impact factor: 17.425

2.  The polymorphism rs975484 in the protein arginine methyltransferase 1 gene modulates expression of immune checkpoint genes in hepatocellular carcinoma.

Authors:  Michael Schonfeld; Jie Zhao; Amberly Komatz; Steven A Weinman; Irina Tikhanovich
Journal:  J Biol Chem       Date:  2020-04-03       Impact factor: 5.157

3.  A Western diet with alcohol in drinking water recapitulates features of alcohol-associated liver disease in mice.

Authors:  Michael Schonfeld; Maura O'Neil; Maria T Villar; Antonio Artigues; Janice Averilla; Sumedha Gunewardena; Steven A Weinman; Irina Tikhanovich
Journal:  Alcohol Clin Exp Res       Date:  2021-09-29       Impact factor: 3.928

4.  The Protective Function of PRMT1 in Alcohol-Induced Hepatocellular Carcinoma.

Authors:  Jong-Min Jeong; Cynthia Ju
Journal:  Hepatol Commun       Date:  2020-05-31

Review 5.  Alcohol and hepatocellular carcinoma.

Authors:  Hiroshi Matsushita; Akinobu Takaki
Journal:  BMJ Open Gastroenterol       Date:  2019-04-03

6.  Hepatocyte PRMT1 protects from alcohol induced liver injury by modulating oxidative stress responses.

Authors:  Jie Zhao; Abby Adams; Steven A Weinman; Irina Tikhanovich
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

7.  Hepatocellular Protein Arginine Methyltransferase 1 Suppresses Alcohol-Induced Hepatocellular Carcinoma Formation by Inhibition of Inducible Nitric Oxide Synthase.

Authors:  Jie Zhao; Maura O'Neil; Michael Schonfeld; Amberly Komatz; Steven A Weinman; Irina Tikhanovich
Journal:  Hepatol Commun       Date:  2020-03-04

8.  TMAO Aggregates Neurological Damage Following Ischemic Stroke by Promoting Reactive Astrocytosis and Glial Scar Formation via the Smurf2/ALK5 Axis.

Authors:  Haibo Su; Shaoping Fan; Lingqiong Zhang; Hui Qi
Journal:  Front Cell Neurosci       Date:  2021-03-18       Impact factor: 5.505

9.  Jumonji: Welcome to the World of Interferon Signaling in Alcohol and HCV.

Authors:  Akshata Moghe; Shirish S Barve; Craig J McClain; Swati Joshi-Barve
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2017-12-09

Review 10.  Jumonji domain-containing protein 6 protein and its role in cancer.

Authors:  Jing Yang; Siyuan Chen; Yanfei Yang; Xuelei Ma; Bin Shao; Shengyong Yang; Yuquan Wei; Xiawei Wei
Journal:  Cell Prolif       Date:  2020-01-21       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.